Therefore, in the HM-1 model, it is possible that CD8+ T cells may not effectively infiltrate the tumor from the blood because of low intratumoral CXCR3 ligand expression, resulting in anti-PD-L1 insensitivity. The gene discussed is CD8A; the disease is neoplasm.